Market cap
₹122 Cr
Revenue (TTM)
₹148 Cr
P/E Ratio
35.6
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹3 Cr
-
ROE
11 %
-
ROCE
15.8 %
-
Industry P/E
33.76
-
EV/EBITDA
6.1
-
Debt to Equity
0.1
-
Book Value
₹131.4
-
EPS
₹5.8
-
Face value
10
-
Shares outstanding
5,900,376
10 Years Aggregate
CFO
₹36.95 Cr
EBITDA
₹68.89 Cr
Net Profit
₹33.91 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Makers Lab
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 18.1 | 3.9 | 8.1 | 16.4 | 22.9 | 14.9 | 12.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Makers Lab
|
206.1 | 121.6 | 148.4 | 11.2 | 9.5 | 4.8 | 35.6 | 1.6 |
| 7,136.0 | 17,802.8 | 2,432.1 | 169.6 | 8.7 | 20.8 | 105 | 19.7 | |
| 2,540.7 | 19,323.3 | 2,287.3 | 678.1 | 31.4 | 19.7 | 29 | 5.1 | |
| 2,083.2 | 12,765.0 | 1,479.1 | 198.6 | 18.6 | 30.3 | 64.1 | 15.8 | |
| 1,312.2 | 18,177.3 | 3,229.7 | 666.9 | 26.6 | 18.8 | 28.2 | 4.5 | |
| 2,408.9 | 38,730.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 54.6 | 9.3 | |
| 4,740.4 | 21,702.5 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29.5 | 4.9 | |
| 5,722.5 | 9,513.6 | 1,432.9 | 356.9 | -- | 58.2 | 26.7 | 15.5 | |
| 901.9 | 17,604.3 | 1,682.5 | 273.5 | 21.0 | 11.1 | 59.2 | 6.6 | |
| 983.0 | 9,055.5 | 5,004.4 | 635.3 | 14.5 | 19.8 | 14.8 | 2.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Makers Lab
Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. The company offers products in general health therapeutic segments, including acid regulatory, anthelmintic, anti-allergic,... anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeal, anti-emetics and anti-nauseants, anti-fungal, anti?inflammatory, analgesic, anti-spasmodic, anti-malarial, anti-thyroid, cough and cold control, digestives, neurotonic, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties. It also provides diabetic and hypertensive drugs. The company's principal formulation brands comprise Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. It serves approximately 1,500 stockiests'; 1,00,000 doctors; and 2,00,000 retailers through a distribution network of 20 consignment agents and 15 super stockiests'. The company was incorporated in 1984 and is based in Mumbai, India. Read more
-
Incorporated
1984
-
Chairman
R K P Verma
-
Managing Director
--
-
Group
Ipca Laboratories
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Makers Laboratories Ltd.’s IPO? Explore our IPO Details page.
FAQs for Makers Lab
What is the current share price of Makers Laboratories Ltd Today?
The share price of Makers Laboratories Ltd is ₹206.11 (NSE) and ₹206.15 (BSE) as of 27-Aug-2026 IST. Makers Laboratories Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Makers Laboratories Ltd?
The P/E ratio of Makers Laboratories Ltd is 35.57 times as on 27-Aug-2026, a 5 premium to its peers’ median range of 33.76 times.
The P/B ratio of Makers Laboratories Ltd is 1.57 times as on 27-Aug-2026, a 68 discount to its peers’ median range of 4.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
33.93 |
1.09 |
2025 |
10.16 |
1.08 |
2024 |
0.00 |
1.05 |
2023 |
0.00 |
0.83 |
2022 |
18.03 |
1.51 |
What is the 52 Week High and Low of Makers Laboratories Ltd?
The 52-week high and low of Makers Laboratories Ltd are Rs 236.00 and Rs 150.00 as of 27-Aug-2026.
What is the market cap of Makers Laboratories Ltd?
Makers Laboratories Ltd has a market capitalisation of ₹ 122 Cr as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Makers Laboratories Ltd?
Before investing in Makers Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.